Gilead (GILD) Insider Discloses 2,500-Share Sale; Recent Sales Total 5,000 Shares

Rhea-AI Filing Summary

Form 144 filing for Gilead Sciences (GILD) shows an insider intends to sell 2,500 common shares through Morgan Stanley Smith Barney on 08/15/2025, with an aggregate market value of $296,325 and the shares listed for sale on NASDAQ. The filing identifies prior acquisitions of the shares as restricted stock granted on 03/10/2024 (1,200 shares) and 03/10/2023 (1,300 shares). The notice also lists sales by the same person during the past three months totaling 5,000 shares with aggregate cash proceeds of approximately $553,000. The filer signs a representation that they are not aware of undisclosed material adverse information about the issuer.

Positive

• Transparent disclosure of planned sale details including broker, date, share count, and aggregate market value.
• Acquisition history provided showing shares were received as restricted stock on 03/10/2023 and 03/10/2024.
• Recent transaction history disclosed showing 5,000 shares sold in the past three months with aggregate proceeds of approximately $553,000.
• Attestation included that the filer represents no knowledge of undisclosed material adverse information.

Negative

• Insider selling activity could be perceived negatively by some investors: 5,000 shares sold in the prior three months.
• Proposed additional sale of 2,500 shares (market value $296,325) scheduled for 08/15/2025.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosure: planned sale of 2,500 shares and recent sales of 5,000 shares totaling roughly $553k.

The filing is a standard Rule 144 notice documenting a proposed sale of 2,500 common shares via Morgan Stanley Smith Barney on 08/15/2025 for an aggregate stated market value of $296,325. It confirms the lots were acquired as restricted stock on 03/10/2023 and 03/10/2024, and provides a complete recent transaction history showing 5,000 shares sold in the prior three months for about $553,000 in gross proceeds. For investors, this is a transparency disclosure of insider liquidity activity rather than a corporate-operational update.

Corporate Governance Expert

TL;DR: Filing documents insider liquidity and includes the standard representation about material non-public information.

This Form 144 contains required broker, lot, and acquisition details and the signer’s attestation that they do not possess undisclosed material adverse information. The notice supports regulatory compliance for an insider sale and helps stakeholders track officer/director/affiliate share disposals. It does not include additional corporate governance actions or changes in control.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	296325.00	1240806916	08/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/10/2024	Restricted Stock	Issuer			1200	03/10/2024	Not Applicable
Common	03/10/2023	Restricted Stock	Issuer			1300	03/10/2023	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	07/15/2025	387	42968.61
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	07/15/2025	1671	185531.13
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	07/15/2025	442	49075.26
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	06/16/2025	1108	122068.36
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	06/16/2025	244	26881.48
ANDREW DICKINSON 333 Lakeside Drive Foster City CA 94404	Common	06/16/2025	1148	126475.16

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for GILD disclose about planned sales?

The filing discloses a proposed sale of 2,500 common shares through Morgan Stanley Smith Barney on 08/15/2025 with an aggregate market value of $296,325.

How many shares did the insider sell in the past three months and for how much?

The filing lists sales totaling 5,000 shares during the past three months for aggregate gross proceeds of approximately $553,000.

When were the shares to be sold originally acquired?

The lots were acquired as restricted stock on 03/10/2023 (1,300 shares) and 03/10/2024 (1,200 shares).

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC.

Does the filer make any representation about material non-public information?

Yes; the filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.